Gene · 4669
Papers3,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Module walking using an SH3-like cell-wall-binding domain leads to a new GH184 family of muramidases. | Acta Crystallogr D Struct Biol | 2023 | 37428847 | PubTator, text mining | PubMed |
| TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. | Cell | 2023 | 37421949 | PubTator, text mining | PubMed |
| Nanocrystal-induced chronic tubular-nephropathy in tropical countries: diagnosis, mitigation, and eradication. | Eur J Med Res | 2023 | 37408060 | PubTator, text mining | PubMed |
| Discordance of light chain isotypes between serum and glomerular deposits in proliferative glomerulonephritis with monoclonal IgG deposits: a case report and review of the literature. | BMC Nephrol | 2023 | 37393252 | PubTator, text mining | PubMed |
| Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy. | World J Diabetes | 2023 | 37383593 | PubTator, text mining | PubMed |
| Protein Biomarkers in Chronic Kidney Disease in Children-What Do We Know So Far? | J Clin Med | 2023 | 37373629 | PubTator, text mining | PubMed |
| Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. | Int J Mol Sci | 2023 | 37372951 | PubTator, text mining | PubMed |
| Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. | Biomolecules | 2023 | 37371567 | PubTator, text mining | PubMed |
| Associations Between Characteristics of Individuals With Fontan Circulation With Blood and Urine Biomarkers of Kidney Injury and Dysfunction. | J Am Heart Assoc | 2023 | 37345835 | PubTator, text mining | PubMed |
| Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial. | Neuropsychopharmacol Rep | 2023 | 37326950 | PubTator, text mining | PubMed |
| Correlation analysis of vaginal microecology and different types of human papillomavirus infection: a study conducted at a hospital in northwest China. | Front Med (Lausanne) | 2023 | 37324149 | PubTator, text mining | PubMed |
| Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design. | RSC Adv | 2023 | 37323463 | PubTator, text mining | PubMed |
| Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation. | Microbiol Spectr | 2023 | 37318366 | PubTator, text mining | PubMed |
| Comparison of microbial colonization between natural and plastic substrata in a polluted watershed. | FEMS Microbiol Ecol | 2023 | 37309047 | PubTator, text mining | PubMed |
| Intraindividual variations of urinary biomarkers in hospitalized children with glomerular diseases: a prospective observational study. | Eur J Pediatr | 2023 | 37300718 | PubTator, text mining | PubMed |
| Renal Biomarkers in Cardiovascular Patients with Acute Kidney Injury: A Case Report and Literature Review. | Diagnostics (Basel) | 2023 | 37296774 | PubTator, text mining | PubMed |
| Evaluation of NAG, NGAL, and KIM-1 as Prognostic Markers of the Initial Evolution of Kidney Transplantation. | Diagnostics (Basel) | 2023 | 37296695 | PubTator, text mining | PubMed |
| A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers. | Front Pharmacol | 2023 | 37288107 | PubTator, text mining | PubMed |
| Review of acute kidney injury and progression to chronic kidney disease in pediatric patients undergoing hematopoietic cell transplant. | Front Oncol | 2023 | 37287918 | PubTator, text mining | PubMed |
| Combining robust urine biomarkers to assess chronic kidney disease progression. | EBioMedicine | 2023 | 37285616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4669/papers?page=15